Press release, 18 October 2021 at 3:00 p.m. (EEST)

Nightingale Health Plc (“Nightingale”) invites investors and analysts to a virtual event An hour with Nightingale on Thursday, October 28th starting at 1 p.m. (EEST).

During the event Nightingale will share its most recent research and development achievements and other current topics. It is possible to ask questions via the webcast platform. A recording of the event will be added to Nightingale’s website later the same day. The event will be held in English.

Registration to participate

To register for the event, please fill out the registration form here: The webcast will be held on the same webpage.

For further information, please contact:

Teemu Suna, CEO

About Nightingale

Nightingale Health is a health technology company transforming preventive care. We envisage a world that focuses on keeping people healthy rather than just treating illnesses. The wide-ranging disease risk predictions provided by Nightingale consist of two interconnected factors: The extensive blood analysis technology developed by Nightingale and a large amount of data on health events. Nightingale helps people make better personal health decisions and connects the health industry to offer their services for individuals’ preventative needs. By empowering the world with comprehensive health insights, we accelerate scientific discoveries, industry developments and improve personal health for everyone.